As hyperglycemia is mediated by alpha-amylase and alpha-glucosidase, which promote digestion, absorption, and metabolism of dietary carbohydrates, these enzymes have been pharmacological targets for treating hyperglycemia, because ordinary pharmacological regulators were associated with adverse abdominal effects and poor patient compliance [60, 65]. The gene discussed is GAA; the disease is Hyperglycemia.